Cantargia AB

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cantargia AB.The latest application filed is for "anti-il1rap antibody compositions".

Company Profile

11.24.27

Cantargia AB - Lund SE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-IL1RAP Antibody Compositions App 20220267454 - Forsberg; Goran ; et al.	2022-08-25
Anti-IL1RAP antibody App 20220242950 - Liberg; David ; et al.	2022-08-04
Anti-IL1-RAP antibodies Grant 11,359,025 - Jiang , et al. June 14, 2	2022-06-14
Anti Human Interleukin-1 Receptor Accessory Protein (IL1 RAP) Antibodies and Uses Thereof App 20220106396 - gerstam; Helena ; et al.	2022-04-07
Methods of producing an IL-1 RAP antibodies Grant 11,236,172 - .ANG.gerstam , et al. February 1, 2	2022-02-01
Anti-IL1RAP Antibodies and Their Use for Treating Humans App 20210261674 - Fioretos; Thoas ; et al.	2021-08-26
Methods of detecting a solid tumor with anti-IL1RAP antibodies Grant 10,995,144 - Fioretos , et al. May 4, 2	2021-05-04
Method of treatment of leukemia with anti-IL1RAP antibodies Grant 10,878,703 - Fioretos , et al. December 29, 2	2020-12-29
Anti Human Interleukin-1 Receptor Accessory Protein (IL1 RAP) Antibodies and Uses Thereof App 20200339696 - gerstam; Helena ; et al.	2020-10-29
Anti human interleukin-1 receptor accessory protein (IL1 RAP) antibodies and uses thereof Grant 10,752,692 - .ANG.gerstam , et al. A	2020-08-25
Method of detection of IL1RAP on cells expressing the protein Grant 10,562,971 - .ANG.gerstam , et al. Feb	2020-02-18
Anti Human Interleukin-1 Receptor Accessory Protein (il1 Rap) Antibodies And Uses Thereof App 20190202924 - GERSTAM ; Helena ; et al.	2019-07-04
Methods of treating cancer using anti human interleukin-1 receptor accessory protein (IL1 RAP) antibodies Grant 10,287,357 - .ANG.gerstam , et al.	2019-05-14
Novel Antibodies And Uses Thereof App 20180355049 - gerstam; Helena ; et al.	2018-12-13
Anti-IL1RAP Antibodies and Their Use for Treating Human App 20180334506 - Fioretos; Thoas ; et al.	2018-11-22
Anti-human interleukin-1 receptor accessory protein antibody and its use for treating cancer Grant 10,100,119 - .ANG.gerstam , et al. October 16, 2	2018-10-16
Novel Agents And Uses Thereof App 20180293895 - Fioretos; Thoas ; et al.	2018-10-11
Method of treatment for leukemia using an anti-IL1RAP antibody Grant 10,005,842 - Fioretos , et al. June 26, 2	2018-06-26
Method of treating a solid tumor with IL1RAP antibodies Grant 10,005,841 - Fioretos , et al. June 26, 2	2018-06-26
Novel Antibodies And Uses Thereof App 20180044425 - gerstam; Helena ; et al.	2018-02-15
Anti Human Interleukin-1 Receptor Accessory Protein (il1 Rap) Antibodies And Uses Thereof App 20180002430 - gerstam; Helena ; et al.	2018-01-04
Anti human interleukin-1 receptor accessory protein (IL1 RAP) antibodies and uses thereof Grant 9,796,783 - .ANG.gerstam , et al. October 24, 2	2017-10-24
Novel Agents And Uses Thereof App 20170198048 - Fioretos; Thoas ; et al.	2017-07-13
Anti-IL1RAP Antibodies and Their Use for Treating Human App 20170081414 - Fioretos; Thoas ; et al.	2017-03-23
Anti Human Interleukin-1 Receptor Accessory Protein (il1 Rap) Antibodies And Uses Thereof App 20170029516 - gerstam; Helena ; et al.	2017-02-02
Method for inducing cell death in acute lymphoblastic leukemic system cells Grant 9,458,237 - Fioretos , et al. October 4, 2	2016-10-04
Method of treatment of a solid tumor with interleukin-1 accessory protein antibody Grant 9,403,906 - Fioretos , et al. August 2, 2	2016-08-02
Anti-IL1RAP Antibodies and Their Use for Treating Human App 20140017167 - Fioretos; Thoas ; et al.	2014-01-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.